HDAC6 and Parkinson disease: In addition to anti-inflammatory effects, inhibition of deacetylation activity of HDAC6 can also limit its modification to α-tubulin or microtubules, therefore increasing the acetylated level of tubulin and the axonal transport function and alleviating damage in PD models [54,55,56,57].